Application of a lacquer acid complex in the preparation of anti-fatigue agents

By preparing a lacquer tree acid complex and applying it to formulations, the problem of poor efficacy of existing anti-fatigue drugs has been solved. This approach achieves effective prevention and improvement of fatigue at low doses, with high safety and broad market prospects.

CN117618408BActive Publication Date: 2026-11-17KUNMING UNIV OF SCI & TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311749447.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-12-19
Publication Date
2026-11-17
Estimated Expiration
2043-12-19

Smart Images

  • Figure CN117618408B_ABST
    Figure CN117618408B_ABST
Patent Text Reader

Abstract

This invention discloses the application of an astragalus acid complex in the preparation of anti-fatigue agents. The invention verifies the effect of an astragalus acid complex derived from sumac fruit in preventing exercise-induced fatigue through animal experiments. Experimental results confirm that the astragalus acid complex has significant preventative and ameliorative effects on fatigue. Furthermore, sumac fruit is an edible plant seasoning with high safety, wide distribution, simple cultivation, and readily available raw materials. For these reasons, the astragalus acid complex has promising prospects for development and utilization in the preparation of fatigue-preventing drugs and functional foods.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the preparation of an astragalus acid complex and its application in the preparation of anti-fatigue and / or anti-fatigue preparations, belonging to the field of pharmaceutical technology. Background Technology

[0002] Fatigue is an activity that is difficult to control and maintain, and it is also a complex physiological phenomenon that includes both mental and physical fatigue. Prolonged or persistent fatigue can cause a series of serious secondary problems, such as cognitive impairment, depression, energy imbalance, and even diseases related to the immune system. Coupled with today's unhealthy diets and lifestyles, lack of exercise and sleep, and chronic mental and psychological stress, fatigue has developed into a serious social problem. Globally, more than one-fifth of the population is affected by fatigue. Of these, about one-third of adults suffer from chronic fatigue, and this number continues to increase with age. Furthermore, chronic fatigue is also associated with diseases such as Parkinson's disease and multiple sclerosis. Although some chemical drugs have anti-fatigue effects, such as cortical stimulants, immune stimulants, antidepressants, and antihistamines, their anti-fatigue effects are unsatisfactory and only effective in the short term. Long-term use can lead to serious adverse reactions and toxic side effects. Therefore, it is necessary to find safer and more effective methods to address the problem of fatigue.

[0003] sumac ( Rhus chinensis *Rhus chinensis* (Mill.) is a plant of the Anacardiaceae family, widely distributed in temperate, subtropical, and tropical regions, and is a valuable economic tree species. Its fruit is pale red or brown and contains a seed with a distinctive sour taste, thus it is widely used in folk medicine as a condiment and beverage. In addition, *Rhus chinensis* fruit contains various phytochemicals such as astaxanthin, phytosterols, tocopherols, and polyphenols, making it rich in nutrients. Folk records indicate that *Rhus chinensis* fruit is often used as a traditional herbal remedy to prevent or treat many diseases, including liver disease, inflammation, and diarrhea. However, there is currently no research on the astaxanthin complex in *Rhus chinensis* fruit, and there are no records or reports regarding the anti-fatigue effects of the astaxanthin complex in *Rhus chinensis* fruit. Summary of the Invention

[0004] This invention provides a novel use for astaxanthin compound, which is derived from sumac fruit. The astaxanthin compound is applied in the preparation of drugs and functional foods for treating and / or preventing fatigue. This invention has demonstrated through multiple pathways that the astaxanthin compound has a significant preventive and ameliorative effect on fatigue.

[0005] The astragalic acid complex is prepared by ultrasonically extracting the fruit of Rhus chinensis with petroleum ether 1-3 times, collecting and combining the supernatants, removing the petroleum ether by rotary evaporation, adding methanol for extraction, collecting the supernatant by standing, concentrating and freeze-drying; the complex contains at least 9 different astragalic acids.

[0006] The formulation of the present invention, for the purpose of anti-fatigue, may also include one or more pharmaceutically acceptable excipients, including fillers, diluents, binders, excipients, absorption enhancers, surfactants, and stabilizers conventional in the pharmaceutical or food fields. Flavoring agents, colorings, and sweeteners may also be added if necessary. In addition to being made into tablets, the formulation may also be made into various pharmaceutically or food-acceptable forms such as pills, powders, capsules, granules, oral liquids, and injections.

[0007] This invention presents a series of studies on the use of astragalic acid complexes from sumac fruit to prevent exercise-induced fatigue. The studies have confirmed that astragalic acid complexes have a definite function in preventing exercise-induced fatigue, and therefore can be used in the preparation and development of new drugs and functional foods for fatigue prevention and treatment. The astragalic acid complexes derived from sumac fruit have the following advantages for preparing drugs and functional foods for fatigue prevention and treatment: sumac plants can adapt to various harsh natural environments, are widely distributed in my country, and the raw materials are readily available in daily life; traditionally, sumac fruit is used as a condiment, and sumac fruit oil is a new food raw material with high safety; the extraction and preparation process is simple, the market prospects are promising, and it holds significant social and economic benefits.

[0008] Compared with the prior art, the present invention has the following advantages: 1. This invention has uncovered new functional food or medical applications for the astragalic acid complex in sumac fruit, opening up a new research field. 2. Through experiments, this invention has found that the astragalic acid complex in sumac fruit can effectively prevent and improve exercise-induced fatigue at low doses, and the extract is derived from edible natural plant raw materials, making it highly safe. Attached Figure Description

[0009] Figure 1 Figure A shows the total ion chromatogram of the asparagus acid complex in negative ion mode; Figure B shows the extracted ion chromatogram of compound 1 in Figure A, and Figure C shows the extracted ion chromatogram of compound 2 in Figure A. Figure 2 This is a schematic diagram showing the results of the weighted swimming time of mice in each experimental group during the weighted swimming experiment. Figure 3 The results of blood lactate (Figure A) and blood urea nitrogen (Figure B) levels in the plasma of mice in each experimental group during the weighted swimming experiment; Figure 4 Figure A shows liver glycogen (Figure A) and muscle glycogen (Figure B) in mice of each experimental group during the weighted swimming experiment. Figure 5 The results show the ATP content in the muscles of mice in each experimental group during the weighted swimming experiment. Figure 6 The results of SOD (Figure A) and GSH-Px (Figure B) content detection in the plasma of mice in each experimental group during the weight-bearing swimming experiment; Figure 7 The results of MDA content detection in the plasma of mice in each experimental group during the weight-bearing swimming experiment; The above values ​​are expressed as mean ± SE (n=12), and there are significant differences in the different letter representations of the same bar chart (p<0.05). Detailed Implementation

[0010] The invention is further illustrated below with data from weighted swimming time and experimental examples. These experimental examples are for illustrative purposes only and are not intended to limit the scope of the invention. After reading this description, any equivalent modifications, alterations, and modifications made by those skilled in the art are within the scope defined by the claims of this invention.

[0011] Example 1: Preparation and component analysis of astaxanthin complex Fresh sumac fruits were collected, pulverized, and petroleum ether was added to the pulverized material at a ratio of 1:5 (g:mL). After mixing, the mixture was ultrasonically extracted at 25℃ for 30 min, centrifuged, and the residue was extracted again with petroleum ether. The supernatants were collected and combined, and the petroleum ether was removed by rotary evaporation at 35℃ to obtain sumac fruit petroleum ether extract. Methanol was added to the sumac fruit petroleum ether extract at a mass-to-volume ratio of 1:5 (g:mL), and the mixture was stirred and extracted at 4℃ for 4 h. After standing and separating the layers, the upper liquid was collected, concentrated by rotary evaporation at 40℃, and freeze-dried to obtain urushiol acid complex (PMRO). 2. Compositional analysis and identification of astaxanthin complex The composition of the astragalic acid complex was analyzed and identified using UHPLC-ESI-HCES / MS. Qualitative and quantitative analysis of the astragalic acid complex was performed using a Thermo Fisher Ultimate 3000 UHPLC system equipped with a Q-Exactive Orbitrap mass spectrometer (Thermo Fisher Scientific, Bremen, Germany). A Poroshell 120 SB-C18 column (Agilent, 2.1 × 100 mm, 2.7 μm, Dr. Maisch, Germany) was used, with an injection volume of 2.0 μL, a flow rate of 0.2 mL / min, and a column temperature of 30 °C. Acidified ultrapure water (0.50% formic acid, phase A) and acetonitrile (phase B) were used as the mobile phases, with the following gradients: 0–2 min, 75% B; 2–27 min, 75%–95% B; 27–32 min, 95%–100% B; 32–35 min, 100% B; 35–65 min, 100%–75% B; 36–40 min, 75% B. Mass spectrometry data were recorded in negative ion mode. Full MS scan was performed, with m / z ranging from 50 to 1000. The relevant MS parameters were set as follows: spray voltage 3.3 kV; capillary temperature: 320 °C; heater temperature: 350 °C; auxiliary gas flow rate: 8.0 L / min; jacket gas flow rate: 32.0 L / min; purge gas: 4.0 L / min; S-lens RF level: 50%. Preliminary identification was performed by comparing the mass spectrometry data of the compound with corresponding standards, databases, or mass spectrometry data reported in the literature. The identified astaxanthin was then semi-quantitatively or quantitatively analyzed based on its corresponding standard curve. Results are as follows: Figure 1 As shown in Table 1, nine compounds were identified in the astragalus acid complex, all belonging to astragalus acid. Astragalus acid is a class of closely related and structurally similar phenolic compounds. Each astragalus acid is composed of a salicylic acid substituted alkyl chain at the 6-position. The alkyl side chains have different lengths (C15-C17) and degrees of saturation (saturated or monoene, diene, and triene). The astragalus acid alkyl long chains identified in the astragalus acid complex have 13, 15, and 17 carbon atoms. Among them, the astragalus acid with 17 carbon saturated and unsaturated alkyl chains has the highest content, accounting for about 62% of the total weight of the complex, mainly including AA(17:0), AA(17:1), AA(17:2), and AA(17:3). Other astragalus acid substances include AA(15:0), AA(15:1), AA(15:3), AA(13:1), and AA(13:0), which account for about 20%. Therefore, the total content of astragalus acid compounds in the astragalus acid complex is about 82%. Table 1 The values ​​in the table are expressed as mean ± standard deviation (n=3); compound 7 was quantified using ascorbic acid (15:0) standard; the remaining compounds were semi-quantified using ascorbic acid (15:0).

[0012] Example 2: Experiment on the prevention and treatment of exercise-induced fatigue in mice induced by weight-bearing swimming using ascorbic acid complex. 1. Establishment of a mouse model of exercise-induced fatigue SPF male KM mice (20g ± 10%) were obtained from Hunan Slack Jingda Experimental Animal Co., Ltd. Sixty mice were divided into five groups (n=12 per group): Group 1: Control group (0.5% Tween-80 aqueous solution administered by gavage), Group 2: Low-dose astaxanthin complex group (50mg / kg astaxanthin complex administered by gavage, L-PMRO), Group 3: Medium-dose astaxanthin complex group (100mg / kg astaxanthin complex administered by gavage, M-PMRO), Group 4: High-dose astaxanthin complex group (150mg / kg astaxanthin complex administered by gavage, H-PMRO), and Group 5: Positive control group (150mg / kg vitamin C administered by gavage, VC). PMRO was dissolved in distilled water containing 0.5% Tween 80, while the control group received the same volume of 0.5% Tween 80 aqueous solution. This intervention was continued for 35 days. 2. Effects of astaxanthin complex on weight-bearing swimming time in mice On day 28 of the intervention, a weight-bearing swimming experiment was conducted. After 30 minutes of gavage treatment, each mouse was placed in a swimming pool with a water depth of 30±1 cm and a water temperature of 25±1℃. A lead weight equal to 5% of the mouse's body weight was fixed to the base of each mouse's tail for weight-bearing. The water surface was stirred with a glass rod to encourage the mice to swim continuously. The time was recorded when a mouse was submerged for more than 10 seconds and could not float to the surface to breathe.

[0013] Decreased exercise endurance is the most direct manifestation of fatigue, and weight-bearing swimming time can directly reflect the body's exercise endurance level. Weight-bearing swimming time is positively correlated with anti-fatigue effects. The weight-bearing swimming times of mice in each experimental group are as follows: Figure 2 As shown, compared with the control group, the weight-bearing swimming time in the M-PMRO group and the H-PMRO group was significantly increased ( p < 0.05), compared with the positive group (VC group), the swimming time of the PMRO medium and low dose intervention groups was similar, with no significant difference. p > 0.05). The swimming time of the high-dose intervention group (H-PMRO) was significantly increased, 2.13 times that of the VC group; the results indicate that PMRO can significantly improve the exercise endurance of mice and has an anti-fatigue effect.

[0014] 3. Effects of astaxanthin complex on key biochemical indicators of energy metabolism After the test in step 2, the mice were quickly removed from the water, dried with paper towels, and returned to their cages. On day 35, after all mice swam without load for 15 minutes, they were anesthetized with isoflurane, blood was collected, and plasma was obtained by centrifugation. The liver and right hind limb gastrocnemius muscle were quickly separated and obtained. The remaining tissues were first frozen in liquid nitrogen and then stored at -80°C for subsequent analysis. Blood urea nitrogen (BUN) and blood lactate (LA) in the plasma, as well as liver glycogen (LG), muscle glycogen (MG), and ATP in the muscle were all detected using the corresponding kits, and the operation was performed according to the kit instructions. ATP is the body's most direct energy source, providing energy for cellular metabolism. Glycogen is the most important energy source for organisms, including liver glycogen and muscle glycogen. During high-intensity exercise, the body first consumes intracellular ATP and glucose, causing a drop in blood sugar. Liver glycogen is broken down to provide glucose for the whole body, maintaining blood sugar levels, while muscle glycogen is broken down for anaerobic respiration. The ATP content in muscles and the body's glycogen stores play an important role in prolonging exercise time. LA is a byproduct of anaerobic respiration, which lowers the pH of blood and muscles, thus causing fatigue and tissue damage. Sustained strenuous exercise can lead to insufficient energy from glycogen and fat metabolism to meet the demands of exercise, stimulating protein breakdown to provide energy, which in turn leads to an increase in BUN levels. Excessive accumulation of BUN and LA causes metabolic disorders, ultimately leading to fatigue. Therefore, LA and BUN levels, as well as LG, MG, and ATP levels, are key indicators for evaluating the degree of post-exercise fatigue. Figure 3 As shown, after 15 minutes of swimming, there was no significant difference in LA and BUN levels between the low-dose PMRO group (L-PMRO group) and the control group. p > 0.05), but the high-dose PMRO group showed significantly lower levels of LA and BUN ( p < 0.05). For example... Figure 4-5 As shown, the glycogen (LG, MG) and ATP contents in the PMRO intervention group and the VC treatment group were significantly increased compared with the Conrol group. p < 0.05), especially in the H-PMRO group, the contents of LG, MG, and ATP were 3.32 times, 2.23 times, and 1.46 times that of the Control group, respectively. The results indicate that PMRO can significantly increase glycogen and ATP content, while the high-dose PMRO treatment group significantly reduced BUN and LA content. Therefore, the astragalic acid complex in sumac fruit may exert its anti-fatigue effect by increasing glycogen storage and reducing BUN and LA content.

[0015] 4. Effects of asparagus acid complex on key biochemical indicators of oxidative stress Strenuous exercise generates excessive ROS, disrupting the balance between the oxidative and antioxidant systems, leading to cellular metabolism and bodily dysfunction, ultimately resulting in fatigue. Superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) protect cell structure and alleviate fatigue by scavenging free radicals; their levels directly reflect the body's ability to scavenge free radicals. Malondialdehyde (MDA) is an important metabolite of oxygen free radicals in the body and is often used as an indicator of the degree of indirect damage from lipid peroxidation; its levels are positively correlated with fatigue levels. Therefore, this study investigated the anti-fatigue effect of PMRO by measuring the levels of SOD, GSH-Px, and MDA. Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and malondialdehyde (MDA) in plasma were detected using appropriate kits, following the kit instructions. See results Figure 6-7 Compared with the control group, the levels of SOD and GSH-Px in the L-PMRO and M-PMRO groups were not significantly increased. p > 0.05), but the H-PMRO group showed a significant increase ( p < 0.05), there was no statistically significant difference in SOD and GSH-Px levels between the H-PMRO group and the VC group. p > 0.05); Compared with the Control group, the MDA content in both the M-PMRO and H-PMRO groups was significantly reduced ( p The results (<0.05) indicate that with increasing PMRO dosage, SOD and GSH-Px levels increased while MDA levels decreased, thus protecting the body from oxidative stress damage. Therefore, mitigating oxidative damage may be part of the reason why the astaxanthin complex in sumac fruit can combat fatigue.

[0016] In conclusion, it can be determined that astaxanthin complex can effectively treat and / or prevent exercise-induced fatigue. Therefore, astaxanthin complex can be used to develop drugs or functional foods for the prevention and treatment of fatigue.

Claims

1. The application of a lacquer acid complex in the preparation of anti-sports fatigue agents; The lacquer acid complex is prepared by ultrasonically extracting the fruit of Rhus chinensis with petroleum ether 1-3 times, collecting and combining the supernatants, removing the petroleum ether by rotary evaporation, adding methanol for extraction, allowing the layers to stand and separate, collecting the upper liquid, concentrating and freeze-drying.